Publications - Zambia

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

Post Date: 
2016-03-19
   |   
Clinical Sites: 
BJGMC
   |   
Countries: 
Brazil
Haiti
India
Kenya
Malawi
Peru
South Africa
Uganda
Zambia
Zimbabwe
Publication: 
The Lancet
Background: Mortality within the first 6 months after initiating antiretroviral therapy is common in resource-limited settings and is often due to tuberculosis in patients with advanced HIV disease. Isoniazid preventive therapy is recommended in HIV-positive adults, but subclinical tuberculosis can...

Taking the long view on CREATE studies' finding

Post Date: 
2014-05-15
   |   
Countries: 
Brazil
South Africa
Zambia
Publication: 
The Lancet Infectious Disease
In the past 10 years, the Consortium to Respond Effectively to the AIDS TB Epidemic (CREATE) has done three large trials exploring new strategies to control HIV-related tuberculosis. Recognising that the global strategy for tuberculosis control of a decade ago (mainly directly observed short-course...